In addition to controlling multiple sclerosis (MS), the approved therapy Mavenclad (cladribine) may also help manage certain coexisting autoimmune diseases, potentially allowing some patients to avoid taking multiple immunosuppressive therapies simultaneously. The findings come from a review of eight adults in the French MS Registry (NCT02889965) who…
Discussion
Certain gut bacteria may influence the odds of developing multiple sclerosis (MS), in part by altering the activity of specific immune cells, according to an analysis of data from tens of thousands of people. While the findings point to possible biological mechanisms linking gut bacteria and MS, the associations…
Discussion
A research team at the University of California, Los Angeles (UCLA) has received a $7.49 million grant to advance a novel cell-based therapy for multiple sclerosis (MS) toward its first clinical trial. The state funding, awarded by the California Institute for Regenerative Medicine (CIRM), was earmarked for a team…
Discussion
I used to think the disease itself would be the hardest thing I’d face as a caregiver. I was wrong. Some days, the heaviest weight isn’t my husband’s illness at all. It’s the people around us who refuse to believe it’s real. My husband, Rhead, was diagnosed with progressive…
Discussion
Nanocurcumin, a dietary supplement containing the turmeric compound curcumin, may significantly improve disability outcomes in people with relapsing-remitting multiple sclerosis (RRMS), according to a review of multiple clinical trials. However, evidence supporting other similar compounds called polyphenols remains limited and inconsistent. The review also found that…
Get regular updates to your inbox.
